Evolution of care for diabetic kidney disease: innovation, collaboration and proactive action
DOI:
https://doi.org/10.47196/diab.v58i2Sup.780Keywords:
diabetes mellitus, nephrology, Argentine Diabetes Society, Argentine Society of NephrologyAbstract
In the field of diabetes mellitus (DM) and nephrology, diabetic kidney disease (DKD) stands out as an unavoidable clinical challenge that requires a critical review of our current strategies. With the increasing prevalence of DM globally and its close interrelationship with chronic kidney disease, it is clear that healthcare requires a radical transformation to effectively address this complex pathology.
Current figures underline the magnitude of the problem: it is estimated that approximately one third or more of patients with DM2 face the risk of developing some degree of ERD, increasing their vulnerability to cardiovascular complications, recurrent hospitalizations, with a notable decrease in their quality of life. life. These statistics invite us to reflect on the trajectory followed to date and to question whether our conventional clinical practices are really addressing the complexity of this multifaceted pathology.
References
I. Gupta S, Domínguez M, Golestaneh L. Diabetic kidney disease: an update. Med Clin North Am 2023 Jul;107(4):689-705. doi: 10.1016/j.mcna.2023.03.004.
II. Akhtar M, Taha NM, Nauman A, Mujeeb IB, Al-Nabet ADMH. Diabetic kidney disease: past and present. Adv Anat Pathol 2020 Mar;27(2):87-97. doi: 10.1097/PAP.0000000000000257.
III. Bonner R, Albajrami O, Hudspeth J, Upadhyay A. Diabetic kidney disease. Prim Care 2020 Dec;47(4):645-659. doi: 10.1016/j.pop.2020.08.004.
IV. Naaman SC, Bakris GL. Diabetic nephropathy: update on pillars of therapy slowing progression. Diabetes Care 2023;46(9):1574-1586.
V. Hu Q, Chen Y, Deng X, Li Y, Ma X, Zeng J, Zhao Y. Diabetic nephropathy: focusing on pathological signals, clinical treatment, and dietary regulation. Biomedicine & Pharmacotherapy 2023;159:114252.
VI. Pillai A, Fulmali D, Fulmali DG. A narrative review of new treatment options for diabetic nephropathy. Cureus 2023;15(1).
VII. Navaneethan SD, Zoungas S, Caramori ML, Chan JC, Heerspink HJ, Hurst C, Khunti K. Diabetes management in chronic kidney disease: synopsis of the KDIGO 2022 clinical practice guideline update. Annals of Internal Medicine 2023;176(3):381-387.
VIII. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes 2024. Diabetes Care 2024;47(Supp1):S219-S230.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 on behalf of the authors. Reproduction rights: Argentine Society of Diabetes
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
